Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: Comparison of full saturation and steady state methods
暂无分享,去创建一个
Yoshihiko Tagawa | Stina Syvänen | Adriaan A. Lammertsma | Carla F. M. Molthoff | Albert D. Windhorst | Elizabeth C. de Lange | Maarten Schenke | Rob A. Voskuyl | A. Lammertsma | A. Windhorst | R. Voskuyl | S. Syvänen | C. Molthoff | E. D. Lange | Y. Tagawa | M. Schenke
[1] Ronald Boellaard,et al. Population Pharmacokinetic Analysis for Simultaneous Determination of Bmax and KDIn Vivo by Positron Emission Tomography , 2005, Molecular Imaging and Biology.
[2] Andrew C. Hooker,et al. Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method , 2007, Pharmaceutical Research.
[3] J. Baron,et al. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.
[4] M Danhof,et al. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Electroencephalogram Effects of GABAA Receptor Modulators: In Vitro-in Vivo Correlations , 2003, Journal of Pharmacology and Experimental Therapeutics.
[5] Wolfgang Löscher,et al. Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABAA receptor ligand binding in a model of temporal lobe epilepsy , 2006, Neurobiology of Disease.
[6] Yasuyoshi Watanabe,et al. Receptor imaging technique with 11C-labeled receptor ligands in living brain slices: its application to time-resolved imaging and saturation analysis of benzodiazepine receptor using [11C]Ro15-1788 , 1996, Neuroscience Research.
[7] Adriaan A Lammertsma,et al. Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations. , 2005, British journal of clinical pharmacology.
[8] T Revesz,et al. Central benzodiazepine receptor autoradiography in hippocampal sclerosis , 1997, British journal of pharmacology.
[9] Bernard Bendriem,et al. Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium Approaches , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] Kazuhiko Yanai,et al. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] M O Karlsson,et al. Diagnosing Model Diagnostics , 2007, Clinical pharmacology and therapeutics.
[12] Sanjiv S. Gambhir,et al. AMIDE: A Free Software Tool for Multimodality Medical Image Analysis , 2003 .
[13] M Danhof,et al. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. , 1991, The Journal of pharmacology and experimental therapeutics.
[14] Jouke Dijkstra,et al. Changes in GABAA receptor properties in amygdala kindled animals: In vivo studies using [11C]flumazenil and positron emission tomography , 2009, Epilepsia.
[15] Lee W. Schruben,et al. Modeling & Analysis , 2003, NeuroImage.
[16] Ronald Boellaard,et al. Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner , 2007, Physics in medicine and biology.
[17] Goonaseelan Pillai,et al. Non-Linear Mixed Effects Modeling – From Methodology and Software Development to Driving Implementation in Drug Development Science , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[18] E N Jonsson,et al. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. , 1999, Computer methods and programs in biomedicine.
[19] Ronald Boellaard,et al. Impact of attenuation correction strategies on the quantification of High Resolution Research Tomograph PET studies , 2008, Physics in medicine and biology.
[20] Ronald Boellaard,et al. HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest Study , 2009, Journal of Nuclear Medicine.
[21] Peter Ott,et al. Blood—Brain Barrier Transport and Protein Binding of Flumazenil and Iomazenil in the Rat: Implications for Neuroreceptor Studies , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Justin J. Wilkins,et al. NONMEMory: A run management tool for NONMEM , 2005, Comput. Methods Programs Biomed..
[23] J. S. Duncan,et al. Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] E. Korpi,et al. Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents , 2010, Pharmacological Reviews.
[25] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] D Comar,et al. Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. , 1984, The International journal of applied radiation and isotopes.
[27] J Delforge,et al. Quantitation of benzodiazepine receptors in human brain using the partial saturation method. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.